Abstract
Objective:
To investigate the pivotal determinants contributing to the adverse prognosis in patients afflicted with traumatic lung injury (TLI), with an aim to mitigate the elevated mortality rate associated with this condition.
Methods:
A retrospective analysis was carried out on 106 TLI patients who were admitted to the intensive care unit of a comprehensive hospital from March 2018 to November 2022. The patients were categorized into two groups based on their 28-day outcome: the survival group (n = 88) and the death group (n = 18). Random forest model, least absolute shrinkage and selection operator (LASSO) regression and support vector machine recursive feature elimination (SVM-RFE) were utilized to pinpoint the primary factors linked to poor prognosis in TLI patients. The Receiver Operating Characteristic (ROC) curve analysis was utilized to ascertain the predictive value of INR in forecasting the prognosis of TLI patients. Based on the cut-off value of INR, patients were categorized into two groups: INR ≥ 1.36 group (n = 35) and INR < 1.36 group (n = 71). The 28-day survival rate was then compared using Kaplan–Meier analysis.
Results:
Random forest model, LASSO, and SVM-RFE jointly identified International standardization ratio (INR) as a risk factor for TLI patients. The area under the ROC curve for INR in predicting the 28-day mortality of TLI patients was 0.826 (95% CI 0.733–0.938), with a cut-off value of 1.36. The 28-day mortality risk for TLI patients with an INR ≥ 1.36 was 8.5 times higher than those with an INR < 1.36.
Conclusion:
Traumatic lung injury patients with elevated INR have a poor prognosis. An INR of ≥1.36 can be used as an early warning indicator for patients with traumatic lung injury.
1 Introduction
Traumatic lung injury (TLI) represents a significant form of pulmonary damage resulting from severe traumatic events, including vehicular collisions, falls from elevation, and severe crush incidents (1). In the context of polytrauma cases, TLI emerges as the predominant injury pattern, constituting approximately 60% of all trauma-related injuries (2). Due to its unique air-containing structure, lung tissue can suffer from pulmonary contusion, bleeding in the airways, tracheal rupture, hemothorax, tension pneumothorax, coagulation disorders, respiratory failure, and even hemorrhagic shock during trauma (3). TLI is complex and often accompanied by multiple injuries, making diagnosis and treatment difficult in emergency conditions (4). According to literature reports, the mortality rate of TLI patients can reach 11–56% (5).
In addition to direct lung tissue damage caused by trauma, trauma-induced inflammatory response and coagulation disorders are also major mechanisms of traumatic lung injury (6). Traumatic inflammatory responses are usually mediated by toll-like receptors (TLRs), followed by the activation of NF-kB, releasing a large amount of inflammatory factors (7). Inflammatory responses can cause polymorphonuclear neutrophils to be recruited to the site of injury, promoting immune thrombosis and further aggravating tissue hypoxia (8). After lung alveolar capillary membrane damage, the permeability of lung tissue increases, which can aggravate pulmonary edema (9).
Although the pathophysiological mechanisms of TLI have been relatively well-understood, there is still a lack of effective indicators for accurately predicting the prognosis of TLI. The lung injury score is related to the occurrence of ARDS, but it is operationally complex and requires blood gas analysis and chest CT before it can be performed (10). Therefore, this study aims to conduct a retrospective analysis of 106 TLI patients treated at a comprehensive hospital to identify better prognostic indicators and guide treatment.
2 Objectives and methods
2.1 Subjects and grouping
A total of 529 traumatic patients admitted to the Intensive Care Unit of the 908th Hospital of Chinese People’s Liberation Army Logistic Support Force from January 2018 to December 2022 were retrospectively analyzed. Inclusion criteria: aged ≥18 years; chest CT results suggest TLI; admission to the intensive care unit within 4 h of injury. Exclusion criteria: without lung injury, known congenital coagulation dysfunction; known underlying lung disease; moderate to severe liver disease; patients receiving anticoagulation therapy; and patients with cardiopulmonary resuscitation before admission. A total of 106 TLI patients were ultimately included (Figure 1). There were 78 males and 28 females, aged 18–88 (48.6 ± 17.5) years. According to the 28-day outcome of TLI patients, they were divided into survival group (n = 88) and death group (n = 18). This study was approved by the Ethics Committee of the 908th Hospital of the Chinese PLA Logistic Support Force (LC2018028).
Figure 1
2.2 Data collection
All patients’ basic data at admission were collected, including gender, age, injury types and sites, Injury Severity Score (ISS), mechanical ventilation and renal replacement treatment. Blood was drawn at the time of admission, and all laboratory analyses were performed within the subsequent 2 h, including blood routine (hemoglobin levels and platelet count), blood gas analysis [oxygenation index (PaO2/FiO2) and serum lactate], routine coagulation tests [activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), antithrombin activity, fibrinogen, D-dimer, and fibrin degradation products (FDPs)], and thromboelastography (TEG) [reaction time (R), clot kinetics (K), clot formation dynamics (Angle), maximum Amplitude (MA), and coagulation index (CI)] (11). The length of stay in the ICU and the outcome were also recorded after the patients were discharged.
2.3 Statistical analysis
The R 4.3 statistical software was utilized for data analysis, with all analyses conducted on a two-sided basis. Count data were expressed as n (%), and compared using the χ2 test. For metric data, the single-sample S-W method was used for normality testing. Data that conformed to a normal distribution were expressed as mean ± standard deviation, while non-normal distribution data were expressed as median (interquartile range). When the data were normally distributed and homoscedastic, a t-test was used for comparison between groups. When the data were not normally distributed or heteroscedastic, a non-parametric rank sum test (Mann–Whitney U test) was used for comparison between groups.
Three algorithms, LASSO regression, SVM-RFE, and random forest, were employed to identify potential risk factors for outcome in patients with TLI. INR was used to evaluate the 28-day mortality of TLI patients, and the ROC curve analysis was performed. The Kaplan–Meier curve was compared between the INR ≥ 1.36 group and the INR < 1.36 group to assess the 28-day survival rate of TLI patients. p < 0.05 was considered statistically significant.
3 Results
3.1 Demographic data
There was no significant difference in age, gender, injury types, and sites between TLI survivors and non-survivors (p > 0.05). However, compared to the survival group, the non-survival group exhibited significantly elevated lactate levels, ISS scores, as well as significantly lower oxygenation indices, hemoglobin concentrations (p < 0.05) (Table 1). Simultaneously, the non-survivors with TLI have a higher proportion of ventilator support and continuous renal-replacement compared to the TLI survivors, and they also spend more time receiving treatment in the ICU. Impressively, TLI fatality cases also exhibit more severe coagulopathy characterized by significantly prolonged APTT and PT, increased INR, and decreased platelet counts, fibrinogen, and antithrombin levels (p < 0.05). Similarly, the non-survivors with TLI also have significantly abnormal TEG indices, with longer R and K times, lower α, MA and CI values compared to survivors. In contrast, there were no significant difference in D-dimer and FDPs between the two groups (p > 0.05).
Table 1
| Survival group (n = 88) | Non-survival group (n = 18) | t/Z/χ2 value | p value | |
|---|---|---|---|---|
| Characteristics | ||||
| Age (years) | 48.4 ± 16.1 | 47.0 ± 19.4 | −0.332 | 0.740 |
| Male, n (%) | 66 (75.0) | 12 (66.7) | 0.534 | 0.465 |
| ISS score (IQR) | 26 (19, 29) | 29 (26, 35) | −2.689 | 0.007 |
| Injury types, n (%) | 0.069 | 0.793 | ||
| Blunt injury | 80 (90.9) | 16 (88.9) | ||
| Sharp injury | 8 (9.1) | 2 (11.1) | ||
| Other injury sites, n (%) | ||||
| Head | 8 (9.1) | 2 (11.1) | 0.138 | 0.711 |
| Abdomen | 46 (52.3) | 10 (55.6) | 0.07 | 0.791 |
| Pelvis | 18 (20.5) | 4 (22.2) | 0.028 | 0.867 |
| Limb | 50 (56.8) | 10 (55.5) | 0.010 | 0.922 |
| Laboratory findings, median (IQR) | ||||
| Oxygenation index | 281 (220, 360) | 138 (63, 218) | −4.390 | 0.000 |
| Hemoglobin, g/L | 100.5 ± 25.7 | 74.3 ± 26.7 | −3.905 | 0.000 |
| Lactate, mmol/L | 2.4 (1.4, 3.7) | 5.3 (3.5, 11.2) | −3.624 | 0.000 |
| Platelet count (×10 9/L) | 78 (111, 160) | 65 (34, 135) | −2.575 | 0.01 |
| Fibrinogen (g/L) | 1.97 (1.53, 3.61) | 1.21 (0.56, 2.98) | −2.394 | 0.017 |
| APTT(s) | 33.6 (28.1, 43.2) | 41.6 (36.7, 63.4) | −3.105 | 0.002 |
| PT(s) | 15.2 (13.3, 16.8) | 20.9 (16.2, 33.9) | −4.313 | 0.000 |
| INR | 1.24 (1.07, 1.35) | 1.70 (1.34, 2.72) | −4.448 | 0.000 |
| TT(s) | 14.1 (11.4, 16.6) | 17.4 (13.2, 24.4) | −2.356 | 0.018 |
| D-Dimer(μg/mL) | 7.6 (3.9, 18.8) | 11.9 (4.3, 27.0) | −0.850 | 0.395 |
| FDP(μg/mL) | 31.0 (13.3, 67.2) | 50.1 (25.9, 93.4) | −1.430 | 0.153 |
| Antithrombin (%) | 64.5 (54.3, 81.8) | 54.8 (45.8, 63.0) | −2.579 | 0.010 |
| TEG parameters | ||||
| R(min) | 7.2 (5.6, 8.6) | 9.6 (7.1, 17.4) | −3.039 | 0.002 |
| K(min) | 2.9 (2.1, 4.2) | 4.3 (2.5, 11.3) | −2.269 | 0.006 |
| Alpha angle (°) | 53.9 (41.7, 60.6) | 31.8 (17.7, 49.9) | −3.092 | 0.002 |
| MA (mm) | 51.2 ± 12.4 | 38.9 ± 19.8 | −2.516 | 0.021 |
| CI | −2.8 (−5.9, −1.0) | −6.5 (−12.1, −3.1) | −2.736 | 0.006 |
| Treatments | ||||
| Mechanical ventilation, n (%) | 53 (66.1) | 15 (83.3) | 9.698 | 0.002 |
| Use of continuous renal-replacement, n (%) | 6 (17) | 9 (50) | 22.937 | 0.000 |
| Length of ICU stay, median (IQR), day | 13.5 (8, 23) | 3.5 (1.0, 18.9) | −3.120 | 0.002 |
Demographic data.
ISS, Injury severity score; APTT, Activated partial thromboplastin time; PT, Prothrombin time; INR, International normalized ratio; TT, Thrombin time; FDP, Fibrin degradation products; TEG, Thromboelastography; R, Reaction time; K, Kinetics time; MA, Maximum amplitude; CI, Coagulation index.
3.2 Screening for predictors of unfavorable outcome in TLI patients
Three algorithms, LASSO regression, SVM-RFE, and random forest, were utilized to screen for indicators that could predict unfavorable outcome in TLI patients. The LASSO regression analysis identified 16 clinical features: Sex, Age, Mechanical ventilation, INR, Platelet counts, PF, Lactate, ISS, WBC, AST, APTT, Fibrinogen, TT, Antithrombin, D-Dimer, and Length of ICU stay (Figure 2). The random forest analysis identified the same six features as LASSO (INR, lactate, Fibrinogen, TT, PF, and APTT) and the other four features: K, Tbil, MA, and Angle (Figures 3A,B). SVM-RFE identified the same one feature as LASSO and random forest (INR), and the following three features: CI, D-Dimer, and Platelet counts (Figure 3C). All three methods overlap the same factor INR, which is considered a potential predictor of poor prognosis with TLI patients (Figure 4).
Figure 2
Figure 3
Figure 4
3.3 Evaluation of INR for predicting unfavorable outcome in TLI patients
Receiver Operating Characteristic curve analysis was performed to evaluate the predictive value of INR for unfavorable outcomes in TLI patients, as shown in Figure 5A. The area under the curve (AUC) was 0.835 (95% CI, 0.733–0.938), indicating a strong predictive power (p < 0.0001). The optimal cut-off value for INR was determined to be 1.36, with a sensitivity of 0.778 and a specificity of 0.761. TLI patients were subsequently stratified into two groups based on the INR cut-off value of 1.36: INR ≥ 1.36 and INR < 1.36. The 28-day survival rate of the INR ≥ 1.36 group was significantly higher than that of the INR < 1.36 group (p < 0.0001). Furthermore, the 28-day mortality risk of the INR ≥ 1.36 group was found to be 8.5 times higher than that of the INR < 1.36 group (Figure 5B).
Figure 5
4 Discussion
This study, for the first time, demonstrates that INR is a risk factor for poor prognosis in TLI patients and proposes that an INR ≥ 1.36 can be employed as an early warning indicator of adverse outcomes in TLI patients. INR is a standardized ratio calculated based on the International Sensitivity Index (ISI) and prothrombin time (PT), which can be used for standardized assessment of hemostasis function (12). PT is the time it takes for blood plasma to clot after the addition of tissue factor and calcium ions. A significant lack of factors VII, X, prothrombin, and fibrinogen in the blood can lead to an extended PT. Among these, factor VII deficiency has the most significant impact (13). During trauma, tissue damage causes a large amount of tissue factor to be released, which can activate factor VII and then promote the formation of a large amount of thrombin through the extrinsic coagulation pathway, resulting in excessive consumption of coagulation substrates (14). Factor VII is often the first coagulation factor to be excessively consumed due to its short half-life of only 6 h (15). Therefore, theoretically, an elevated INR is a sensitive indicator for identifying traumatic coagulopathy (16).
Our study findings reveal that the 28-day mortality risk significantly increases in TLI patients with INR ≥ 1.36. Compared to general trauma patients, TLI patients face multiple unique challenges in coagulation dysfunction: Firstly, TLI patients often experience severe physiological disturbances, such as hypothermia and acidosis, which significantly exacerbate coagulation dysfunction. While these issues may occur in general trauma, they are typically more severe and difficult to correct in TLI patients due to impaired lung function (17, 18). Secondly, TLI patients often suffer from contusions and rib fractures, leading to unique changes in respiratory mechanics. Chest wall instability not only affects respiratory function but may also directly damage vascular endothelium through sustained mechanical stress, activating the coagulation cascade. This mechanism is rare in other types of trauma (19, 20). These factors contribute to hypoxemia, which directly impacts the synthesis and function of coagulation factors and may cause platelet dysfunction and endothelial cell damage. This persistent hypoxic state, uncommon in other trauma types, is a key feature of TLI-related coagulation dysfunction (21, 22). Notably, the inflammatory response in TLI is also unique. Lung tissue damage releases numerous inflammatory mediators that can enter the systemic circulation directly through pulmonary circulation, affecting the body’s coagulation system. This widespread inflammatory response may lead to more severe coagulation imbalances compared to localized trauma (23–28). Thirdly, tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA), synthesized and released by pulmonary endothelial cells, both facilitate the degradation of fibrin within the blood vessels and exacerbate lung injury. Additionally, uPA promotes the degradation of fibrin in the extrapulmonary matrix, intensifying the edema of pulmonary tissue (29–32). Lastly, TLI patients often require mechanical ventilation support, which can further affect coagulation by increasing intrathoracic pressure and impacting venous return. This treatment-related effect on coagulation is less common in other types of trauma (33). This highlights the importance of early identification and timely correction of coagulopathy in TLI patients.
Interestingly, the diagnostic criteria for coagulopathy resulting from different injury sites are not uniform. The general diagnostic criteria for traumatic coagulopathy are an INR > 1.5 (34); coagulopathy associated with brain injury is diagnosed with an INR > 1.3 (35); our study indicates that an INR ≥ 1.36 is the diagnostic criteria for traumatic lung injury-related coagulopathy. This variation is related to the distinct pathophysiological mechanisms of coagulopathy associated with different injury sites. For instance, brain injury can easily cause intracranial hypertension and neuroendocrine disorders, and the abundant capillaries in the brain are susceptible to endothelial damage, leading to coagulation activation (36). Consequently, the INR value for the diagnosis of brain injury-related coagulopathy is lower than that of lung injury.
Naturally, there are several limitations to this study that should be acknowledged: firstly, the research is a retrospective, single-center analysis with a limited sample size. While the results are suggestive, they require confirmation through multi-center studies to enhance their generalizability and credibility. Secondly, the study population consists of polytrauma patients with traumatic lung injury as the principal injury, rather than patients with isolated traumatic lung injury. This selection is more reflective of the typical clinical scenario. As a result, we meticulously tallied the data from the combined injury sites to ensure that any differences between groups were not attributable to the nature of the injury site. Thirdly, due to considerations of data integrity, this study collected data only at the time of patient admission, without continuous monitoring of coagulation test indicators. Fourthly, hypothermia was not factored into our analysis as a variable. In future research, we are committed to refining and substantiating our experimental findings.
In conclusion, this study has demonstrated that an INR of ≥1.36 can serve as a valuable indicator of poor prognosis in patients with TLI and can be employed as a criterion for initiating treatment for TLI-related coagulopathy.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material; further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving humans were approved by the Ethics Committee of the 908th Hospital of Chinese PLA Logistic Support Force. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements.
Author contributions
QL: Conceptualization, Writing – original draft. EP: Data curation, Writing – review & editing. XD: Data curation, Writing – review & editing. XS: Data curation, Writing – review & editing. LZ: Formal Analysis, Writing – review & editing. LH: Validation, Writing – review & editing. QZ: Validation, Writing – review & editing. JS: Conceptualization, Funding acquisition, Writing – original draft, Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Acknowledgments
We thank the patients for participating in our study.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
SaitoYSakaoY. Traumatic lung injury. Kyobu Geka. (2022) 75:835–40.
2.
HomoRLGrigorianALekawaMDolichMKuzaCMDobenARet al. Outcomes after pneumonectomy versus limited lung resection in adults with traumatic lung injury. Updat Surg. (2020) 72:547–53. doi: 10.1007/s13304-020-00727-4
3.
PlatzJJFabricantLNorotskyM. Thoracic trauma: injuries, evaluation, and treatment. Surg Clin North Am. (2017) 97:783–99. doi: 10.1016/j.suc.2017.03.004
4.
LeeHKKimHSHaSOParkSLeeHSLeeSKet al. Clinical outcomes of extracorporeal membrane oxygenation in acute traumatic lung injury: a retrospective study. Scand J Trauma Resusc Emerg Med. (2020) 28:41. doi: 10.1186/s13049-020-00733-w
5.
BroderickJCManchaFLongBJMaddryJKChungKKSchauerSG. Combat trauma-related acute respiratory distress syndrome: a scoping review. Crit Care Explor. (2022) 4:e0759. doi: 10.1097/CCE.0000000000000759
6.
JanicovaAReljaB. Neutrophil phenotypes and functions in trauma and trauma-related Sepsis. Shock. (2021) 56:16–29. doi: 10.1097/SHK.0000000000001695
7.
XiangMFanJFanJ. Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury. Mediat Inflamm. (2010) 2010:916425. doi: 10.1155/2010/916425
8.
PerdomoJLeungHHL. Immune thrombosis: exploring the significance of immune complexes and NETosis. Biology. (2023) 12:1332. doi: 10.3390/biology12101332
9.
DogrulBNKiliccalanIAsciESPekerSC. Blunt trauma related chest wall and pulmonary injuries: an overview. Chin J Traumatol. (2020) 23:125–38. doi: 10.1016/j.cjtee.2020.04.003
10.
StörmannPLustenbergerTReljaBMarziIWutzlerS. Role of biomarkers in acute traumatic lung injury. Injury. (2017) 48:2400–6. doi: 10.1016/j.injury.2017.08.041
11.
WhittonTPHealyWJ. Review of thromboelastography (TEG): medical and surgical applications. Ther Adv Pulm Crit Care Med. (2023) 18:29768675231208426. doi: 10.1177/29768675231208426
12.
SonJKimEM. Evaluating the effect of timing on point-of-care testing of INR. J Pharm Pract. (2023) 37:703–707. doi: 10.1177/08971900231177198
13.
FitzmauriceDAGeersingGJArmoiryXMachinSKitchenSMackieI. ICSH guidance for INR and D-dimer testing using point of care testing in primary care. Int J Lab Hematol. (2023) 45:276–81. doi: 10.1111/ijlh.14051
14.
PalmerLMartinL. Traumatic coagulopathy-part 1:pathophysiology and diagnosis. J Vet Emerg Crit Care. (2014) 24:63–74. doi: 10.1111/vec.12130
15.
BellestLEschwègeVPouponRChazouillèresORobertA. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology. (2007) 46:528–34. doi: 10.1002/hep.21680
16.
MooreEEMooreHBKornblithLZNealMDHoffmanMMutchNJet al. Trauma-induced coagulopathy. Nat Rev Dis Primers. (2021) 7:30. doi: 10.1038/S41572-021-00264-3
17.
KleinveldDJBHamadaSRSandroniC. Trauma-induced coagulopathy. Intensive Care Med. (2022) 48:1642–5. doi: 10.1007/s00134-022-06834-7
18.
WangZXuSQiuZZhengCChengFLiLet al. Effect of sodium bicarbonate Ringer’s solution on lung injury in rats with traumatic hemorrhagic shock. J Biochem Mol Toxicol. (2024) 38:e23608. doi: 10.1002/jbt.23608
19.
LiJZhangJShiMYuSJiMLiangYet al. Crosstalk between inflammation and hemorrhage/coagulation disorders in primary blast lung injury. Biomol Ther. (2023) 13:351. doi: 10.3390/biom13020351
20.
MadukaAKILinGJLimWWLeeDJKKangMLVenkatesanKet al. A comprehensive analysis of traumatic rib fractures in an acute general hospital in Singapore. J Emerg Trauma Shock. (2019) 12:145–9. doi: 10.4103/JETS.JETS_72_18
21.
GaoJZhangZYanJYGeYXGaoY. Inflammation and coagulation abnormalities via the activation of the HMGB1-RAGE/NF-κB and F2/rho pathways in lung injury induced by acute hypoxia. Int J Mol Med. (2023) 52:67. doi: 10.3892/ijmm.2023.5270
22.
FawleyJATignanelliCJWernerNLKasotakisGMandellSPGlassNEet al. American Association for the Surgery of Trauma/American College of Surgeons Committee on trauma clinical protocol for management of acute respiratory distress syndrome and severe hypoxemia. J Trauma Acute Care Surg. (2023) 95:592–602. doi: 10.1097/TA.0000000000004046
23.
GandoSLeviMTohCH. Trauma-induced innate immune activation and disseminated intravascular coagulation. J Thromb Haemost. (2024) 22:337–51. doi: 10.1016/j.jtha.2023.09.028
24.
KustermannMDasariPKnapeIKeltschELiuJPflügerSet al. Adoptively transferred in vitro-generated myeloid-derived suppressor cells improve T-cell function and antigen-specific immunity after traumatic lung injury. J Innate Immun. (2022) 15:78–95. doi: 10.1159/000525088
25.
ShaoXFLiBShenJWangQFChenSSJiangXCet al. Ghrelin alleviates traumatic brain injury-induced acute lung injury through pyroptosis/NF-κB pathway. Int Immunopharmacol. (2020) 79:106175. doi: 10.1016/j.intimp.2019.106175
26.
HalátGHaiderTDedeyanMHeinzTHajduSNegrinLLet al. IL-33 and its increased serum levels as an alarmin for imminent pulmonary complications in polytraumatized patients. World J Emerg Surg. (2019) 14:36. doi: 10.1186/s13017-019-0256-z
27.
HuL-YCuiJ-BXuX-MHuangZHJiaoHT. Expression of Nrf2-Keap1-ARE signal pathway in traumatic lung injury and functional study. Eur Rev Med Pharmacol Sci. (2018) 22:1402–8. doi: 10.26355/eurrev_201803_14486
28.
JianminLChanyuanPChaoTTanWLiuHGuanJ. The reaction pathway of miR-30c-5p activates lipopolysaccharide promoting the course of traumatic and hemorrhagic shock acute lung injury. Biomed Res Int (2022) 2022::3330552. doi: 10.1155/2022/3330552
29.
TuckerTAIdellS. The contribution of the Urokinase plasminogen activator and the Urokinase receptor to pleural and parenchymal lung injury and repair: a narrative review. Int J Mol Sci. (2021) 22:1437. doi: 10.3390/ijms22031437
30.
BdeirKMurcianoJCTomaszewskiJKoniarisLMartinezJCinesDBet al. Urokinase mediates fibrinolysis in the pulmonary microvasculature. Blood. (2000) 96:1820–6. doi: 10.1182/blood.V96.5.1820
31.
Cesarman-MausGHajjarKA. Molecular mechanisms of fibrinolysis. Br J Haematol. (2005) 129:307–21. doi: 10.1111/j.1365-2141.2005.05444.x
32.
SitrinRG. Plasminogen activation in the injured lung: pulmonology does not recapitulate hematology. Am J Respir Cell Mol Biol. (1992) 6:131–2. doi: 10.1165/ajrcmb/6.2.131
33.
BosLDJWareLB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet. (2022) 400:1145–56. doi: 10.1016/S0140-6736(22)01485-4
34.
SchöchlHSchmittFCFMaegeleM. Pathophysiology of trauma-induced coagulopathy. Hamostaseologie. (2024) 44:031–9. doi: 10.1055/a-2215-8936
35.
DongJFZhangFZhangJ. Detecting traumatic brain injury-induced coagulopathy: what we are testing and what we are not. J Trauma Acute Care Surg. (2023) 94:S50–5. doi: 10.1097/TA.0000000000003748
36.
LiuLDengQJ. Role of platelet-derived extracellular vesicles in traumatic brain injury-induced coagulopathy and inflammation. Neural Regen Res. (2022) 17:2102–7. doi: 10.4103/1673-5374.335825
Summary
Keywords
trauma, lung injury, coagulopathy, international normalized ratio, prognosis
Citation
Lin Q, Peng E, Deng X, Song X, Zhong L, He L, Zeng Q and Song J (2024) Elevated international normalized ratio contributes to poor prognosis in patients with traumatic lung injury. Front. Med. 11:1426999. doi: 10.3389/fmed.2024.1426999
Received
02 May 2024
Accepted
22 July 2024
Published
02 August 2024
Volume
11 - 2024
Edited by
Sebastian Schnaubelt, Medical University of Vienna, Austria
Reviewed by
Philip Verdonck, Antwerp University Hospital, Belgium
Roman Brock, Medical University of Vienna, Austria
Updates
Copyright
© 2024 Lin, Peng, Deng, Song, Zhong, He, Zeng and Song.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jingchun Song, songjingchun@126.com
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.